Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €58.00 Price Target at Morgan Stanley

Morgan Stanley set a €58.00 ($67.44) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a report published on Wednesday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

FME has been the subject of a number of other research reports. Independent Research set a €74.00 ($86.05) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research report on Monday, June 17th. UBS Group set a €92.00 ($106.98) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Tuesday, July 30th. Jefferies Financial Group set a €68.00 ($79.07) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research report on Friday, June 28th. Deutsche Bank set a €100.00 ($116.28) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Wednesday, July 31st. Finally, HSBC set a €93.00 ($108.14) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Thursday, April 25th. Seven equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The stock has an average rating of Buy and a consensus target price of €80.49 ($93.59).

Shares of FME stock opened at €60.60 ($70.47) on Wednesday. Fresenius Medical Care AG & Co. KGaA has a fifty-two week low of €55.44 ($64.47) and a fifty-two week high of €91.74 ($106.67). The stock has a market cap of $18.50 billion and a P/E ratio of 15.03. The business has a fifty day simple moving average of €64.57 and a 200-day simple moving average of €68.41. The company has a quick ratio of 0.63, a current ratio of 0.99 and a debt-to-equity ratio of 105.19.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Featured Article: What is the Coverage Ratio?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.